Mingli Sun
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- MicroRNA in disease regulation 6
-
- RNA modifications and cancer 5
- Co-authors
- Xinan Zhang (9 shared papers)Zhaojin Yu (19 shared papers)Minjie Wei (17 shared papers)Lin Zhao (11 shared papers)Dan Feng Dong (7 shared papers)Chenghai Zhao (3 shared papers)Yong‐Xiang Wang (4 shared papers)Qian Huang (4 shared papers)
- Journals
- Optics Express (6 papers)Frontiers in Pharmacology (4 papers)Food & Function (3 papers)Oncology Reports (3 papers)Life Sciences (3 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Mingli Sun
108 papers receiving 3k citations
Mingli Sun's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 326
- Molecular Biology 1.1k
- Rheumatology 159
- Oncology 253
- Pulmonary and Respiratory Medicine 309
Countries citing papers authored by Mingli Sun
This map shows the geographic impact of Mingli Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingli Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingli Sun more than expected).
Fields of papers citing papers by Mingli Sun
This network shows the impact of papers produced by Mingli Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingli Sun. The network helps show where Mingli Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingli Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally Hit paper breakdown → | 2019 | 558 |
| 2 | Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma Hit paper breakdown → | 2015 | 334 |
| 3 | The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia Hit paper breakdown → | 2022 | 263 |
| 4 | 2013 | 92 | |
| 5 | 2023 | 84 | |
| 6 | 2018 | 63 | |
| 7 | 2019 | 60 | |
| 8 | 2021 | 57 | |
| 9 | 2024 | 57 | |
| 10 | 2014 | 56 | |
| 11 | 2019 | 54 | |
| 12 | 2014 | 52 | |
| 13 | 2016 | 50 | |
| 14 | 2022 | 50 | |
| 15 | 2016 | 49 | |
| 16 | 2017 | 46 | |
| 17 | 2018 | 44 | |
| 18 | 2020 | 41 | |
| 19 | 2009 | 38 | |
| 20 | 2015 | 38 |
About Mingli Sun
Mingli Sun is a scholar working on Cancer Research, Molecular Biology, Rheumatology, Oncology and Atomic and Molecular Physics, and Optics, having authored 112 papers that have together received 3k indexed citations. Recurring topics across this work include Orbital Angular Momentum in Optics (10 papers), Radical Photochemical Reactions (7 papers), Osteoarthritis Treatment and Mechanisms (6 papers), Pain Mechanisms and Treatments (6 papers), MicroRNA in disease regulation (6 papers), Nutritional Studies and Diet (5 papers), RNA modifications and cancer (5 papers) and Paraquat toxicity studies and treatments (4 papers). The work is most often cited by research in Cancer Research (326 citations), Molecular Biology (1.1k citations), Rheumatology (159 citations), Oncology (253 citations) and Pulmonary and Respiratory Medicine (309 citations). Mingli Sun has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Xinan Zhang, Zhaojin Yu, Minjie Wei, Lin Zhao, Dan Feng Dong, Chenghai Zhao, Yong‐Xiang Wang, Qian Huang, Miao He and Pinhua Li. Their work appears in journals such as Optics Express, Frontiers in Pharmacology, Food & Function, Oncology Reports and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.